Clinical Trial Update: Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

View source ↗

Summary

A clinical trial evaluating dalpiciclib for hormone receptor-positive advanced breast cancer is currently recruiting, with the aim to assess efficacy and safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Dalpiciclib (dalpiciclib)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Breast Cancer | Status: RECRUITING